{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:51:00Z","timestamp":1790070660309,"version":"4.0.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T00:00:00Z","timestamp":1510790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The fragile X mental retardation protein (FMRP) is lacking or mutated in patients with the fragile X syndrome (FXS), the most frequent form of inherited intellectual disability. FMRP affects metastasis formation in a mouse model for breast cancer. Here we show that FMRP is overexpressed in human melanoma with high Breslow thickness and high Clark level. Furthermore, meta-analysis of the TCGA melanoma data revealed that high levels of FMRP expression correlate significantly with metastatic tumor tissues, risk of relapsing and disease-free survival. Reduction of FMRP in metastatic melanoma cell lines impinges on cell migration, invasion and adhesion. Next-generation sequencing in human melanoma cells revealed that FMRP regulates a large number of mRNAs involved in relevant processes of melanoma progression. Our findings suggest an association between FMRP levels and the invasive phenotype in melanoma and might open new avenues towards the discovery of novel therapeutic targets.<\/jats:p>","DOI":"10.1038\/cddis.2017.521","type":"journal-article","created":{"date-parts":[[2017,11,16]],"date-time":"2017-11-16T13:57:12Z","timestamp":1510840632000},"page":"e3169-e3169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["The fragile X mental retardation protein regulates tumor invasiveness-related pathways in melanoma cells"],"prefix":"10.1038","volume":"8","author":[{"given":"Francesca","family":"Zalfa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Panasiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Carotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Zingariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sancillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavie","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Roberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Osella","family":"Abate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Alba","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Fiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Melocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giulia","family":"Farace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Achsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Marine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"BFcddis2017521_CR1","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1172\/JCI63141","volume":"122","author":"C Bagni","year":"2012","unstructured":"Bagni C, Tassone F, Neri G, Hagerman R . Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. J Clin Invest 2012; 122: 4314\u20134322.","journal-title":"J Clin Invest"},{"key":"BFcddis2017521_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-neuro-060909-153138","volume":"35","author":"AL Bhakar","year":"2012","unstructured":"Bhakar AL, Dolen G, Bear MF . The pathophysiology of fragile X (and what it teaches us about synapses). Annu Rev Neurosci 2012; 35: 417\u2013443.","journal-title":"Annu Rev Neurosci"},{"key":"BFcddis2017521_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/npp.2011.137","volume":"37","author":"C Gross","year":"2012","unstructured":"Gross C, Berry-Kravis EM, Bassell GJ . Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. N europsychoparmacology 2012; 37: 178\u2013195.","journal-title":"N europsychoparmacology"},{"key":"BFcddis2017521_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0092-8674(03)00079-5","volume":"112","author":"F Zalfa","year":"2003","unstructured":"Zalfa F, Giorgi M, Primerano B, Moro A, Di Penta A, Reis S et al. The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 2003; 112: 317\u2013327.","journal-title":"Cell"},{"key":"BFcddis2017521_CR5","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cell.2008.07.031","volume":"134","author":"I Napoli","year":"2008","unstructured":"Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell 2008; 134: 1042\u20131054.","journal-title":"Cell"},{"key":"BFcddis2017521_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cell.2011.06.013","volume":"146","author":"JC Darnell","year":"2011","unstructured":"Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, Fraser CE et al. FMRP stalls ribosomal transocation on mRNAs linked to synaptic function and autism. Cell 2011; 146: 247\u2013261.","journal-title":"Cell"},{"key":"BFcddis2017521_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainres.2006.08.115","volume":"1121","author":"C D'Hulst","year":"2006","unstructured":"D'Hulst C, De Geest N, Reeve SP, Van Dam D, De Deyn PP, Hassan BA et al. Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res 2006; 1121: 238\u2013245.","journal-title":"Brain Res"},{"key":"BFcddis2017521_CR8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nn1893","volume":"10","author":"F Zalfa","year":"2007","unstructured":"Zalfa F, Eleuteri B, Dickson KS, Mercaldo V, De Rubeis S, Di Penta A et al. A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 2007; 10: 578\u2013587.","journal-title":"Nat Neurosci"},{"key":"BFcddis2017521_CR9","doi-asserted-by":"publisher","first-page":"10057","DOI":"10.1073\/pnas.0700169104","volume":"104","author":"M Zhang","year":"2007","unstructured":"Zhang M, Wang Q, Huang Y . Fragile X mental retardation protein FMRP and the RNA export factor NXF2 associate with and destabilize Nxf1 mRNA in neuronal cells. Proc Natl Acad Sci USA 2007; 104: 10057\u201310062.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017521_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.mcn.2009.09.013","volume":"43","author":"S De Rubeis","year":"2010","unstructured":"De Rubeis S, Bagni C . Fragile X mental retardation protein control of neuronal mRNA metabolism: Insights into mRNA stability. Mol Cell Neurosci 2010; 43: 43\u201350.","journal-title":"Mol Cell Neurosci"},{"key":"BFcddis2017521_CR11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.devcel.2008.04.003","volume":"14","author":"JB Dictenberg","year":"2008","unstructured":"Dictenberg JB, Swanger SA, Antar LN, Singer RH, Bassell GJ . A direct role for FMRP in activity-dependent dendritic mRNA transport links filopodial-spine morphogenesis to fragile X syndrome. Dev Cell 2008; 14: 926\u2013939.","journal-title":"Dev Cell"},{"key":"BFcddis2017521_CR12","doi-asserted-by":"publisher","first-page":"15601","DOI":"10.1073\/pnas.1010564107","volume":"107","author":"DI Kao","year":"2010","unstructured":"Kao DI, Aldridge GM, Weiler IJ, Greenough WT . Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein. Proc Natl Acad Sci USA 2010; 107: 15601\u201315606.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcddis2017521_CR13","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/nn.2950","volume":"14","author":"B Bhogal","year":"2011","unstructured":"Bhogal B, Jaepson JE, Savva YA, Pepper AS, Reenan RA, Jongens TA . Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein. Nat Neurosci 2011; 14: 1517\u20131524.","journal-title":"Nat Neurosci"},{"key":"BFcddis2017521_CR14","doi-asserted-by":"publisher","first-page":"e1005702","DOI":"10.1371\/journal.pgen.1005702","volume":"11","author":"A Shamay-Ramot","year":"2015","unstructured":"Shamay-Ramot A, Khermesh K, Porath HT, Barak M, Pinto Y, Wachtel C et al. Fmrp Interacts with Adar and regulates RNA editing, synaptic density and locomotor activity in zebrafish. PLoS Genet 2015; 11: e1005702.","journal-title":"PLoS Genet"},{"key":"BFcddis2017521_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.conb.2008.07.015","volume":"18","author":"RS Schmid","year":"2008","unstructured":"Schmid RS, Maness PF . L1 and NCAM adhesion molecules as signaling coreceptors in neuronal migration and process outgrowth. Curr Opin Neurobiol 2008; 18: 245\u2013250.","journal-title":"Curr Opin Neurobiol"},{"key":"BFcddis2017521_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10555-008-9167-2","volume":"28","author":"TY Kim","year":"2009","unstructured":"Kim TY, Vigil D, Der CJ, Juliano RL . Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev 2009; 28: 77\u201383.","journal-title":"Cancer Metastasis Rev"},{"key":"BFcddis2017521_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ajmg.1533","volume":"103","author":"S Schultz-Pedersen","year":"2001","unstructured":"Schultz-Pedersen S, Hasle H, Olsen JH, Friedrich U . Evidence of decreased risk of cancer in individuals with fragile X. Am J Med Genet 2001; 103: 226\u2013230.","journal-title":"Am J Med Genet"},{"key":"BFcddis2017521_CR18","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1002\/emmm.201302847","volume":"5","author":"R Luca","year":"2013","unstructured":"Luca R, Averna M, Zalfa F, Vecchi M, Bianchi F, La Fata G et al. The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med 2013; 5: 1523\u20131536.","journal-title":"EMBO Mol Med"},{"key":"BFcddis2017521_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00432-003-0493-z","volume":"129","author":"Y Li","year":"2003","unstructured":"Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 2003; 129: 43\u201351.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BFcddis2017521_CR20","first-page":"943","volume":"18","author":"Y Liu","year":"2007","unstructured":"Liu Y, Zhu X, Zhu J, Liao S, Tang Q, Liu K et al. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. Oncol Rep 2007; 18: 943\u2013951.","journal-title":"Oncol Rep"},{"key":"BFcddis2017521_CR21","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/adc.2006.103382","volume":"92","author":"R Kalkunte","year":"2007","unstructured":"Kalkunte R, Macarthur D, Morton R . Glioblastoma in a boy with fragile X: an unusual case of neuroprotection. Arch Dis Child 2007; 92: 795\u2013796.","journal-title":"Arch Dis Child"},{"key":"BFcddis2017521_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-016-0028-x","volume":"7","author":"J Qian","year":"2017","unstructured":"Qian J, Chen H, Ji X, Eisenberg R, Chakravarthy AB, Mayer IA, Massion PP . A 3q gene signature associated with triple negative breast cancer organ specific metastasis and response to neoadjuvant chemotherapy. Sci Rep 2017; 7: 1\u20139.","journal-title":"Sci Rep"},{"key":"BFcddis2017521_CR23","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1016\/j.cell.2014.08.035","volume":"158","author":"E Pasciuto","year":"2014","unstructured":"Pasciuto E, Bagni C . SnapShot: FMRP mRNA targets and diseases. Cell 2014; 158: 1446\u20131446.e1.","journal-title":"Cell"},{"key":"BFcddis2017521_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3322\/caac.21149","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T et al. Cancer treatment and survivorship statistics 2012 CA Cancer J Clin 2012; 62: 220\u2013241.","journal-title":"CA Cancer J Clin"},{"key":"BFcddis2017521_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/pcmr.12041","volume":"26","author":"JL Orgaz","year":"2013","unstructured":"Orgaz JL, Sanz-Moreno V . Emerging molecular targets in melanoma invasion and metastasis. Pigment Cell Melanoma Res 2013; 26: 39\u201357.","journal-title":"Pigment Cell Melanoma Res"},{"key":"BFcddis2017521_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0046-8177(84)80310-X","volume":"15","author":"WH Clark Jr","year":"1984","unstructured":"Clark WH Jr, Elder DE, Guerry D 4th, Epstein MN, Greene MH, Van Horn M . A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147\u20131165.","journal-title":"Hum Pathol"},{"key":"BFcddis2017521_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<275::AID-JCP35>3.0.CO;2-C","volume":"173","author":"M Bar-Eli","year":"1997","unstructured":"Bar-Eli M . Molecular mechanisms of melanoma metastasis. J Cell Physiol 1997; 173: 275\u2013278.","journal-title":"J Cell Physiol"},{"key":"BFcddis2017521_CR28","first-page":"1225","volume":"13","author":"MR Luca","year":"1998","unstructured":"Luca MR, Bar-Eli M . Molecular changes in human melanoma metastasis. Histol Histopathol 1998; 13: 1225\u20131231.","journal-title":"Histol Histopathol"},{"key":"BFcddis2017521_CR29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.mcn.2006.11.015","volume":"34","author":"F Ferrari","year":"2007","unstructured":"Ferrari F, Mercaldo V, Piccoli G, Sala C, Cannata S, Achsel T, Bagni C . The fragile X mental retardation protein\u2013RNP granules show an mGluR-dependent localization in the post-synaptic spines. Mol Cell Neurosci 2007; 34: 343\u2013354.","journal-title":"Mol Cell Neurosci"},{"key":"BFcddis2017521_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/nm.2863","volume":"18","author":"A Gembarska","year":"2012","unstructured":"Gembarska A, Luciani F, Fedele C, Russell EA, Dewaele M, Villar S et al. MDM4 is a key therapeutic target in cutaneous melanoma. Nat Med 2012; 18: 1239\u20131247.","journal-title":"Nat Med"},{"key":"BFcddis2017521_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00008390-199304000-00006","volume":"3","author":"M Luca","year":"1993","unstructured":"Luca M, Hunt B, Bucana CD, Johnson JP, Fidler IJ, Bar-Eli M . Direct correlation between MUC18 expression and metastatic potential of human melanoma cells. Melanoma Res 1993; 3: 35\u201341.","journal-title":"Melanoma Res"},{"key":"BFcddis2017521_CR32","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","volume":"51","author":"DJ Giard","year":"1973","unstructured":"Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP . In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973; 51: 1417\u20131423.","journal-title":"J Natl Cancer Inst"},{"key":"BFcddis2017521_CR33","first-page":"3058","volume":"41","author":"T Tsuruo","year":"1981","unstructured":"Tsuruo T, Fidler IJ . Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Res 1981; 41: 3058\u20133064.","journal-title":"Cancer Res"},{"key":"BFcddis2017521_CR34","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1093\/nar\/gkr1254","volume":"40","author":"C Lacoux","year":"2012","unstructured":"Lacoux C, Di Marino D, Boyl PP, Zalfa F, Yan D, Ciotti MT . BC1-FMRP interaction is modulated by 2'-O-methylation: RNA-binding activity of the tudor domain and translational regulation at synapses. Nucleic Acids Res 2012; 40: 4086\u20134096.","journal-title":"Nucleic Acids Res"},{"key":"BFcddis2017521_CR35","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11033-006-9032-8","volume":"34","author":"K Singh","year":"2007","unstructured":"Singh K, Gaur P, Prasad S . Fragile x mental retardation (Fmr-1) gene expression is down regulated in brain of mice during aging. Mol Biol Rep 2007; 34: 173\u2013181.","journal-title":"Mol Biol Rep"},{"key":"BFcddis2017521_CR36","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1023\/B:NEON.0000024220.07063.70","volume":"67","author":"D Del Duca","year":"2004","unstructured":"Del Duca D, Werbowetski T, Del Maestro RF . Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 2004; 67: 295\u2013303.","journal-title":"J Neurooncol"},{"key":"BFcddis2017521_CR37","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.aanat.2010.12.005","volume":"193","author":"K Hattermann","year":"2011","unstructured":"Hattermann K, Held-Feindt J, Mentlein R . Spheroid confrontation assay: a simple method to monitor the three-dimensional migration of different cell types in vitro. Ann Anat 2011; 193: 181\u2013184.","journal-title":"Ann Anat"},{"key":"BFcddis2017521_CR38","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1523\/JNEUROSCI.0937-07.2007","volume":"27","author":"RS Muddashetty","year":"2007","unstructured":"Muddashetty RS, Kelic S, Gross C, Xu M, Bassell GJ . Dysregulated metabotropic glutamate receptor-dependent translation of AMPA receptor and postsynaptic density-95 mRNAs at synapses in a mouse model of fragile X syndrome. J Neurosci 2007; 27: 5338\u20135348.","journal-title":"J Neurosci"},{"key":"BFcddis2017521_CR39","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00018-012-1115-1","volume":"70","author":"WJ Polacheck","year":"2013","unstructured":"Polacheck WJ, Zervantonakis IK, Kamm RD . Tumor cell migration in complex microenvironments. Cell Mol Life Sci 2013; 70: 1335\u20131356.","journal-title":"Cell Mol Life Sci"},{"key":"BFcddis2017521_CR40","first-page":"647","volume":"20","author":"F Tas","year":"2012","unstructured":"Tas F . Metastatic behavior in melanoma: timing, pattern, survival, and influencing factors. J Oncol 2012; 20: 647\u2013684.","journal-title":"J Oncol"},{"key":"BFcddis2017521_CR41","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.ad.2011.08.009","volume":"103","author":"RM Mart\u00ed","year":"2012","unstructured":"Mart\u00ed RM, Sorolla A, Yeramian A . New therapeutic targets in melanoma. Actas Dermosifiliogr 2012; 103: 579\u2013590.","journal-title":"Actas Dermosifiliogr"},{"key":"BFcddis2017521_CR42","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djp038","volume":"101","author":"BE Gould Rothberg","year":"2009","unstructured":"Gould Rothberg BE, Bracken MD, Rimm DL . Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis. J Natl Cancer Inst 2009; 101: 452\u2013474.","journal-title":"J Natl Cancer Inst"},{"key":"BFcddis2017521_CR43","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/ajmg.a.36241","volume":"161A","author":"C Bagni","year":"2013","unstructured":"Bagni C, Oostra BA . Fragile X syndrome: from protein function to therapy. Am J Med Genet A 2013; 161A: 2809\u20132821.","journal-title":"Am J Med Genet A"},{"key":"BFcddis2017521_CR44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12022-009-9070-6","volume":"20","author":"MS Adams","year":"2009","unstructured":"Adams MS, Bronner-Fraser M . Review: the role of neural crest cells in the endocrine system. Endocr Pathol 2009; 20: 92\u2013100.","journal-title":"Endocr Pathol"},{"key":"BFcddis2017521_CR45","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/BF02616120","volume":"14","author":"R Cailleau","year":"1978","unstructured":"Cailleau R, Oliv\u00e9 M, Cruciger QV . Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization. In Vitro 1978; 14: 911\u2013915.","journal-title":"In Vitro"},{"key":"BFcddis2017521_CR46","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/73432","volume":"24","author":"DT Ross","year":"2000","unstructured":"Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24: 227\u2013235.","journal-title":"Nat Genet"},{"key":"BFcddis2017521_CR47","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA . Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFcddis2017521_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10555-008-9169-0","volume":"28","author":"M Yilmaz","year":"2009","unstructured":"Yilmaz M, Christofori G . EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009; 28: 15\u201333.","journal-title":"Cancer Metastasis Rev"},{"key":"BFcddis2017521_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012; 485: 55\u201361.","journal-title":"Nature"},{"key":"BFcddis2017521_CR50","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc2824","volume":"10","author":"D Silvera","year":"2010","unstructured":"Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2010; 10: 254\u2013266.","journal-title":"Nat Rev Cancer"},{"key":"BFcddis2017521_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.gde.2011.03.007","volume":"21","author":"CR Stumpf","year":"2011","unstructured":"Stumpf CR, Ruggero D . The cancerous translation apparatus. Curr Opin Genet Dev 2011; 21: 474\u2013483.","journal-title":"Curr Opin Genet Dev"},{"key":"BFcddis2017521_CR52","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.devcel.2009.08.012","volume":"17","author":"RH Insall","year":"2009","unstructured":"Insall RH, Machesky LM . Actin dynamics at the leading edge: from simple machinery to complex networks. Dev Cell 2009; 17: 310\u2013322.","journal-title":"Dev Cell"},{"key":"BFcddis2017521_CR53","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.cell.2011.06.010","volume":"145","author":"AJ Ridley","year":"2011","unstructured":"Ridley AJ . Life at the leading edge. Cell 2011; 145: 1012\u20131022.","journal-title":"Cell"},{"key":"BFcddis2017521_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wrna.1265","volume":"6","author":"G Liao","year":"2015","unstructured":"Liao G, Mingle L, Van De Water L, Liu G . Control of cell migration through mRNA localization and local translation. Wiley Interdiscip Rev RNA 2015; 6: 1\u201315.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"BFcddis2017521_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.neuron.2004.07.022","volume":"43","author":"Y Kanai","year":"2004","unstructured":"Kanai Y, Dohmae N, Hirokawa N . Kinesin transports RNA: isolation and characterization of an RNA-transporting granule. Neuron 2004; 43: 513\u2013525.","journal-title":"Neuron"},{"key":"BFcddis2017521_CR56","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/hmg\/ddm263","volume":"16","author":"L Davidovic","year":"2007","unstructured":"Davidovic L, Jaglin XH, Lepagnol-Bestel AM, Tremblay S, Simonneau M, Bardoni B, Khandjian EW . The fragile X mental retardation protein is a molecular adaptor between the neurospecific KIF3C kinesin and dendritic RNA granules. Hum Mol Genet 2007; 16: 3047\u20133058.","journal-title":"Hum Mol Genet"},{"key":"BFcddis2017521_CR57","doi-asserted-by":"publisher","first-page":"37804","DOI":"10.1074\/jbc.M203608200","volume":"277","author":"S Ohashi","year":"2002","unstructured":"Ohashi S, Koike K, Omori A, Ichinose S, Ohara S, Kobayashi S et al. Identification of mRNA\/protein (mRNP) complexes containing Puralpha, mStaufen, fragile X protein, and myosin Va and their association with rough endoplasmic reticulum equipped with a kinesin motor. J Biol Chem 2002; 277: 37804\u201337810.","journal-title":"J Biol Chem"},{"key":"BFcddis2017521_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature06888","volume":"453","author":"S Mili","year":"2008","unstructured":"Mili S, Moissoglu K, Macara IG . Genome-wide screen reveals APC-associated RNAs enriched in cell protrusions. Nature 2008; 453: 115\u2013119.","journal-title":"Nature"},{"key":"BFcddis2017521_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/boc.201200076","volume":"106","author":"AJ Lindsay","year":"2014","unstructured":"Lindsay AJ, McCaffrey MW . Myosin Va is required for the transport of fragile X mental retardation protein (FMRP) granules. Biol Cell 2014; 106: 57\u201371.","journal-title":"Biol Cell"},{"key":"BFcddis2017521_CR60","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1097\/PAT.0b013e328363b3bd","volume":"45","author":"JM Brandner","year":"2013","unstructured":"Brandner JM, Haass NK . Melanoma's connections to the tumour microenvironment. Pathology 2013; 45: 443\u2013452.","journal-title":"Pathology"},{"key":"BFcddis2017521_CR61","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/bjc.2014.452","volume":"111","author":"CA Whipple","year":"2014","unstructured":"Whipple CA, Brinckerhoff CE . BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity. Br J Cancer 2014; 111: 1625\u20131633.","journal-title":"Br J Cancer"},{"key":"BFcddis2017521_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/PAP.0b013e3182976c94","volume":"20","author":"JF Solus","year":"2013","unstructured":"Solus JF, Kraft S . Ras, Raf, and MAP kinase in melanoma. Adv Anat Pathol 2013; 20: 217\u2013226.","journal-title":"Adv Anat Pathol"},{"key":"BFcddis2017521_CR63","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.18632\/oncotarget.3141","volume":"6","author":"D Alonso-Curbelo","year":"2015","unstructured":"Alonso-Curbelo D, Soengas MS . Hyperactivated endolysosomal trafficking in melanoma. Oncotarget 2015; 6: 2583\u20132584.","journal-title":"Oncotarget"},{"key":"BFcddis2017521_CR64","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.4161\/auto.28594","volume":"10","author":"ML Goodall","year":"2014","unstructured":"Goodall ML, Wang T, Martin KR, Kortus MG, Kauffman AL, Trent JM et al. Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib. Autophagy 2014; 10: 1120\u20131136.","journal-title":"Autophagy"},{"key":"BFcddis2017521_CR65","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrd3482","volume":"10","author":"A Flemming","year":"2011","unstructured":"Flemming A . Cancer: autophagy presents Achilles heel in melanoma. Nat Rev Drug Discov 2011; 10: 491.","journal-title":"Nat Rev Drug Discov"},{"key":"BFcddis2017521_CR66","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s10522-014-9531-2","volume":"15","author":"D Campos-Melo","year":"2014","unstructured":"Campos-Melo D, Droppelmenn CA, Volkening K, Strong MJ . RNA-binding proteins as molecular links between cancer and neurodegeneration. Biogerontology 2014; 15: 587\u2013610.","journal-title":"Biogerontology"},{"key":"BFcddis2017521_CR67","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1128\/MCB.24.7.2915-2922.2004","volume":"24","author":"J Goodall","year":"2004","unstructured":"Goodall J, Martinozzi S, Dexter TJ, Champeval D, Carreira S, Larue L, Goding CR . Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin. Mol Cell Biol 2004; 24: 2915\u20132922.","journal-title":"Mol Cell Biol"},{"key":"BFcddis2017521_CR68","doi-asserted-by":"publisher","first-page":"7516","DOI":"10.1158\/0008-5472.CAN-05-3189","volume":"66","author":"G Robert","year":"2006","unstructured":"Robert G, Gaggioli C, Bailet O, Chavey C, Abbe P, Aberdam E et al. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res 2006; 66: 7516\u20137523.","journal-title":"Cancer Res"},{"key":"BFcddis2017521_CR69","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009; 27: 6199\u20136206.","journal-title":"J Clin Oncol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cddis2017521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017521","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cddis.2017.521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cddis2017521.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T18:52:59Z","timestamp":1671735179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cddis2017521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,16]]},"references-count":69,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11]]}},"alternative-id":["BFcddis2017521"],"URL":"https:\/\/doi.org\/10.1038\/cddis.2017.521","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,16]]},"assertion":[{"value":"8 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}